UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2022-07, Vol.25 (4), p.794-803

2022

Volltextzugriff (PDF)

Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study

Cancers, 2022-03, Vol.14 (7), p.1747

2022

Volltextzugriff (PDF)

STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer

Journal for immunotherapy of cancer, 2021-06, Vol.9 (6), p.e002195

2021

Volltextzugriff (PDF)

Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma

Therapeutic advances in medical oncology, 2023-01, Vol.15, p.17588359221148541-17588359221148541

2023

Volltextzugriff (PDF)

Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation

Supportive care in cancer, 2021-02, Vol.29 (2), p.975-986

2021

Volltextzugriff (PDF)

The c-Abl inhibitor, radotinib induces apoptosis in multiple myeloma cells via mitochondrial-dependent pathway

Scientific reports, 2021-06, Vol.11 (1), p.13198-13198, Article 13198

2021

Volltextzugriff (PDF)

Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment

Cancer medicine (Malden, MA), 2023-02, Vol.12 (3), p.2731-2738

2023

Volltextzugriff (PDF)

Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy

Therapeutic advances in medical oncology, 2021, Vol.13, p.17588359211003053-17588359211003053

2021

Volltextzugriff (PDF)

Atezolizumab plus bevacizumab in Child-Pugh B advanced hepatocellular carcinoma patients

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.397-397

2022

Volltextzugriff (PDF)

The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma

Therapeutic advances in medical oncology, 2022, Vol.14, p.17588359221113266-17588359221113266

2022

Volltextzugriff (PDF)

Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events

Liver international, 2020-09, Vol.40 (9), p.2263-2271

2020

Volltextzugriff (PDF)

Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

Therapeutic advances in medical oncology, 2021, Vol.13, p.17588359211035983-17588359211035983

2021

Volltextzugriff (PDF)

High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma

Cancers, 2022-12, Vol.14 (23), p.5985

2022

Volltextzugriff (PDF)

High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma

JHEP reports, 2023-04, Vol.5 (4), p.100672, Article 100672

2023

Volltextzugriff (PDF)

Pegteograstim prophylaxis for chemotherapy-induced neutropenia and febrile neutropenia: a prospective, observational, postmarketing surveillance study in Korea

Supportive care in cancer, 2021-09, Vol.29 (9), p.5383-5390

2021

Volltextzugriff (PDF)

LIGHT (TNFSF14) enhances osteogenesis of human bone marrow-derived mesenchymal stem cells

PloS one, 2021-02, Vol.16 (2), p.e0247368-e0247368

2021

Volltextzugriff (PDF)

Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis

Liver cancer (Basel ), 2020-09, Vol.9 (5), p.613-624

2020

Volltextzugriff (PDF)

Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death

BMC cancer, 2020-12, Vol.20 (1), p.1193-15, Article 1193

2020

Volltextzugriff (PDF)

Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920923424-1758835920923424

2020

Volltextzugriff (PDF)

High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancer

Journal for immunotherapy of cancer, 2021-10, Vol.9 (10), p.e003353

2021

Volltextzugriff (PDF)

Management of the adverse effects of cancer immunotherapy with a focus on the gastrointestinal and hepatic systems

Taehan Ŭisa Hyŏphoe chi, 2023-02, Vol.66 (2), p.112-115

Cheon, Jaekyung

2023

Volltextzugriff (PDF)

CD45dimCD34+CD38−CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia

BMC cancer, 2020-04, Vol.20 (1), p.1-285, Article 285

2020

Volltextzugriff (PDF)

Radotinib inhibits mitosis entry in acute myeloid leukemia cells via suppression of Aurora kinase A expression

Tumor biology, 2019-05, Vol.41 (5), p.1010428319848612-50

2019

Volltextzugriff (PDF)

A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY

Cancers, 2022-01, Vol.14 (3), p.559

2022

Volltextzugriff (PDF)

Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act

BMC palliative care, 2021-04, Vol.20 (1), p.63-63, Article 63

2021

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(128)

Publikationsform

Artikel
(146)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab

Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study

STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer

Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma

Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation

The c-Abl inhibitor, radotinib induces apoptosis in multiple myeloma cells via mitochondrial-dependent pathway

Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment

Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy

Atezolizumab plus bevacizumab in Child-Pugh B advanced hepatocellular carcinoma patients

The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma

Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events

Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma

High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma

Pegteograstim prophylaxis for chemotherapy-induced neutropenia and febrile neutropenia: a prospective, observational, postmarketing surveillance study in Korea

LIGHT (TNFSF14) enhances osteogenesis of human bone marrow-derived mesenchymal stem cells

Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis

Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death

Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis

High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancer

Management of the adverse effects of cancer immunotherapy with a focus on the gastrointestinal and hepatic systems

CD45dimCD34+CD38−CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia

Radotinib inhibits mitosis entry in acute myeloid leukemia cells via suppression of Aurora kinase A expression

A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY

Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act

Suchergebnisse filtern